Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by himmleron Jan 03, 2019 8:32pm
197 Views
Post# 29184250

RE:RE:RE:RE:Bristol Meyers acquiring Celgene for $74 billion USD

RE:RE:RE:RE:Bristol Meyers acquiring Celgene for $74 billion USDHi Francois..yes that was a response to you,and I really do think that this BB has degenerated in the last year or so.However,I(we) know whos been here and who has held on this stock for so long.We all have our reasons for still owning the stock,and certainly dont need useless daily negativety by the same people.We can see the share price for ourselves.
I will hope for the best ,as we all do.Nothing else can be said or done at this point anyways.
Bullboard Posts